Survivin expression induced by doxorubicin in cholangiocarcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 3

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

352

HTML

2428

Figures (1-3)

179

Tables (1-3)

176

Sum=3135

Feb 1, 2004 (publication date) through Nov 26, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Clinical Research

World J Gastroenterol. Feb 1, 2004; 10(3): 415-418
Published online Feb 1, 2004. doi: 10.3748/wjg.v10.i3.415

Table 3 Expression level of survivin protein

Data were expressed as mean ± SD, b vs C (48 h after adding doxorubicin), d vs B (24 h after adding doxorubicin), A: Normal Qbc939.

Citation: Chang Q, Liu ZR, Wang DY, Kumar M, Chen YB, Qin RY. Survivin expression induced by doxorubicin in cholangiocarcinoma. World J Gastroenterol 2004; 10(3): 415-418
URL: https://www.wjgnet.com/1007-9327/full/v10/i3/415.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i3.415